Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2021-01-11
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if the combination of vosaroxin and
decitabine can help to control AML or MDS. The safety of these drugs will also be studied.